CIDRAP newsletters options
Resources may be especially taxed in some US cities with vulnerable populations.
In a study today in the Journal of the Pediatric Infectious Diseases Society, US and Colombian researchers report that nearly one-third of the pediatric invasive Candida bloodstream infections (BSIs) analyzed at two Colombian pediatric hospitals were caused by Candida auris.
A study published today in Pediatrics shows Chinese children who contracted COVID-19 often presented with co-infections of other respiratory viruses.
The man was treated on Dec 27, 2019—4 days before a COVID-19 cluster was identified in Wuhan, China.
Of those polled, 78% say they would be uncomfortable in a sit-down restaurant.
Cases rose 41% in Africa last week, and transmission is widespread in 7 countries. Lesotho is the only nation that hasn't reported a case.
US drug maker Pfizer Inc. and Germany biopharmaceutical company BioNTech announced today that the first US participants in a clinical trial for a novel coronavirus vaccine have begun receiving doses.
Nations and groups pledge $8 billion to make the ACT Accelerator a reality.
The report seeks to bridge the gap between current practice and the need to protect health workers.
Leaked White House documents say deaths will climb to 3,000 a day by Jun 1.
The Food and Drug Administration (FDA) today said that it's revising a policy that aimed to accelerate the availability of COVID-19 antibody tests in the wake of reports that some companies have been marketing fraudulent tests.
Spain, the world's second hardest-hit country after the US, is taking cautious steps to ease its 7-week lockdown, while the US CDC launches a gene tracking consortium to help with response.
Experts urge the WHO to develop guidance for the gradual return of passenger travel.
COVID-19 meat plant outbreaks have been noted in at least 5 Midwestern states.
Among the challenges highlighted in the report are limited data and lack of timely information.
The Global Antibiotic Research and Development Partnership (GARDP) this week announced a partnership with Venatorx Pharmaceuticals to accelerate development of an investigational beta-lactam/beta-lactamase inhibitor combination for treating multidrug-resistant hospital infections.
Though many organization have published guidance on the best way forward during this COVID-19 pandemic, the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota saw a need for recommendations based on current realities and restrictions, not on technology such as widespread testing that may one day be in place.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The UK will release a plan to begin loosening restrictions next week.
The opening of states is now in the hands of governors.
